India · Delayed Price · Currency is INR NSE:ADVENZYMES Statistics
Total Valuation
NSE:ADVENZYMES has a market cap or net worth of INR 31.25 billion. The enterprise value is 25.61 billion.
| Market Cap | 31.25B |
| Enterprise Value | 25.61B |
Important Dates
The last earnings date was Tuesday, November 3, 2026.
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | Jul 24, 2026 |
Share Statistics
NSE:ADVENZYMES has 111.15 million shares outstanding. The number of shares has increased by 0.04% in one year.
| Current Share Class | 111.15M |
| Shares Outstanding | 111.15M |
| Shares Change (YoY) | +0.04% |
| Shares Change (QoQ) | -0.22% |
| Owned by Insiders (%) | 40.13% |
| Owned by Institutions (%) | 10.80% |
| Float | 35.94M |
Valuation Ratios
The trailing PE ratio is 18.44.
| PE Ratio | 18.44 |
| Forward PE | n/a |
| PS Ratio | 4.00 |
| PB Ratio | 1.82 |
| P/TBV Ratio | 2.50 |
| P/FCF Ratio | 37.31 |
| P/OCF Ratio | 18.46 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.99, with an EV/FCF ratio of 30.58.
| EV / Earnings | 14.99 |
| EV / Sales | 3.28 |
| EV / EBITDA | 10.99 |
| EV / EBIT | 13.01 |
| EV / FCF | 30.58 |
Financial Position
The company has a current ratio of 8.91, with a Debt / Equity ratio of 0.03.
| Current Ratio | 8.91 |
| Quick Ratio | 6.92 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.23 |
| Debt / FCF | 0.64 |
| Interest Coverage | 67.81 |
Financial Efficiency
Return on equity (ROE) is 10.95% and return on invested capital (ROIC) is 13.83%.
| Return on Equity (ROE) | 10.95% |
| Return on Assets (ROA) | 6.84% |
| Return on Invested Capital (ROIC) | 13.83% |
| Return on Capital Employed (ROCE) | 11.01% |
| Weighted Average Cost of Capital (WACC) | 7.89% |
| Revenue Per Employee | 19.11M |
| Profits Per Employee | 4.18M |
| Employee Count | 409 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 1.16 |
Taxes
In the past 12 months, NSE:ADVENZYMES has paid 621.83 million in taxes.
| Income Tax | 621.83M |
| Effective Tax Rate | 25.87% |
Stock Price Statistics
The stock price has decreased by -9.42% in the last 52 weeks. The beta is 0.67, so NSE:ADVENZYMES's price volatility has been lower than the market average.
| Beta (5Y) | 0.67 |
| 52-Week Price Change | -9.42% |
| 50-Day Moving Average | 279.63 |
| 200-Day Moving Average | 308.70 |
| Relative Strength Index (RSI) | 56.85 |
| Average Volume (20 Days) | 266,406 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:ADVENZYMES had revenue of INR 7.82 billion and earned 1.71 billion in profits. Earnings per share was 15.25.
| Revenue | 7.82B |
| Gross Profit | 5.63B |
| Operating Income | 1.97B |
| Pretax Income | 2.40B |
| Net Income | 1.71B |
| EBITDA | 2.26B |
| EBIT | 1.97B |
| Earnings Per Share (EPS) | 15.25 |
Balance Sheet
The company has 6.73 billion in cash and 536.99 million in debt, with a net cash position of 6.19 billion or 55.69 per share.
| Cash & Cash Equivalents | 6.73B |
| Total Debt | 536.99M |
| Net Cash | 6.19B |
| Net Cash Per Share | 55.69 |
| Equity (Book Value) | 17.20B |
| Book Value Per Share | 149.78 |
| Working Capital | 9.26B |
Cash Flow
In the last 12 months, operating cash flow was 1.69 billion and capital expenditures -854.97 million, giving a free cash flow of 837.64 million.
| Operating Cash Flow | 1.69B |
| Capital Expenditures | -854.97M |
| Depreciation & Amortization | 285.94M |
| Net Borrowing | -65.85M |
| Free Cash Flow | 837.64M |
| FCF Per Share | 7.54 |
Margins
Gross margin is 72.00%, with operating and profit margins of 25.20% and 21.86%.
| Gross Margin | 72.00% |
| Operating Margin | 25.20% |
| Pretax Margin | 30.75% |
| Profit Margin | 21.86% |
| EBITDA Margin | 28.86% |
| EBIT Margin | 25.20% |
| FCF Margin | 10.72% |
Dividends & Yields
This stock pays an annual dividend of 5.35, which amounts to a dividend yield of 1.90%.
| Dividend Per Share | 5.35 |
| Dividend Yield | 1.90% |
| Dividend Growth (YoY) | -74.04% |
| Years of Dividend Growth | 5 |
| Payout Ratio | 8.67% |
| FCF Payout Ratio | 17.91% |
| Buyback Yield | -0.04% |
| Shareholder Yield | 1.87% |
| Earnings Yield | 5.42% |
| FCF Yield | 2.68% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
The last stock split was on May 25, 2017. It was a forward split with a ratio of 5.
| Last Split Date | May 25, 2017 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |